Skip to main content
. Author manuscript; available in PMC: 2016 May 2.
Published in final edited form as: J Reconstr Microsurg. 2013 Mar 5;29(4):213–222. doi: 10.1055/s-0032-1329921

Table 2.

The effectiveness of perioperative gabapentin for chronic pain

Positive Studies
Surgery type Patients Most remote
follow-up
Positive findings Negative findings
Abdominal hysterectomy99 25 1 month Gabapentin reduced incidence
of pain 1 month after surgery.
Did not identify a statistically
significant decrease in
immediate postoperative pain
Inguinal herniorrhaphy100 30 6 months Gabapentin reduced pain
scores at 1, 3, and 6 months
after surgery. The number of
patients with daily activity
adversely affected by pain was
lower in the gabapentin group
at 1 month.
The number of patients whose
daily activities were adversely
affected by pain was similar
between groups at 3 months
and 6 months
Abdominal hysterectomy101 20 6 months Gabapentin reduced pain
scores, pain impact, and
incidence of pain at 1, 3, and
6 months.
Pain impact on activities of
daily living was not
significantly different at
6 months
Thyroidectomy102 23 6 months Gabapentin reduced total pain
score and the incidence of
more intense pain at 6 months.
Nonsignificant trend toward
decreased burning sensation
and numbness in the
gabapentin group.
Mastectomy16 50 6 months At 6 months gabapentin
reduced the incidence of
burning pain.
Gabapentin did not reduce
global pain severity and opioid
use at 6 months.
Breast cancer surgery17** 22 3 months Gabapentin and mexiletine
each reduced the incidence of
burning pain at 3 months.
Gabapentin did not reduce the
incidence of chronic pain, or
patients requiring analgesics at
3 months.
Breast cancer surgery103** 20 6 months Gabapentin reduced the
incidence of chronic pain and
analgesic use at 3 months.
Gabapentin did not reduce the
incidence of chronic pain, and
analgesic use at 6 months.
Abdominal hysterectomy104 27 1 month Gabapentin reduced the
incidence of pain at 1 month.
Gabapentin did not reduce the
incidence of analgesic use at
1 month.
Negative Studies
Surgery type Patients* Most remote
follow-up
Positive findings Negative findings
Coronary artery bypass graft
surgery18
20 3 months Gabapentin reduced pain
intensity immediately after
surgery
Gabapentin did not reduce
pain intensity at 1 month and
3 months.
Total hip arthroplasty19 28 6 months None Gabapentin did not reduce
pain at any time point (one
third of patients lost to remote
follow-up).
Cesarean delivery20 16 3 months Gabapentin improved acute
but not chronic pain.
Gabapentin failed to reduce
persistent pain, or median pain
scores at 3 months.
Lower limb amputation21 15 6 months None Gabapentin failed to reduce
the incidence and intensity of
pain at 6 months.
*

Indicates the number of gabapentin patients per group available for most remote follow-up.

**

Modified radical mastectomy or lumpectomy with axillary lymph node dissection.